These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32216735)

  • 1. Should the Vancomycin Minimal Inhibitory Concentration be used as an Infant Critical Care Regular Criteria?
    Bidu NS; Fernandes BJD; Filho JNC; Bastos REA; Pedreira JNR; Couto RD
    Curr Pharm Biotechnol; 2020; 21(11):1052-1058. PubMed ID: 32216735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
    Sinkeler FS; de Haan TR; Hodiamont CJ; Bijleveld YA; Pajkrt D; Mathôt RA
    BMC Pediatr; 2014 Jul; 14():193. PubMed ID: 25066951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosage adjustment of vancomycin in continuous infusion in critically ill-patients].
    Carricajo A; Forgeot A; Morel J; Auboyer C; Zeni F; Aubert G
    Ann Fr Anesth Reanim; 2010 Jan; 29(1):55-7. PubMed ID: 20074899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant
    Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
    J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Serum Trough Concentrations and High Vancomycin Minimum Inhibitory Concentration in Methicillin-Sensitive Staphylococcus aureus From Hemodialysis Patients in Brazil.
    Vitória MPD; Alvarenga CGS; Vasconcellos Filho LM; Birro JCT; Barbosa MC; Ferreira MAM; Schuenck RP; Nunes APF; Santos KVD
    Ther Drug Monit; 2019 Feb; 41(1):38-43. PubMed ID: 30520829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case Series.
    Bidu NS; Fernandes BJD; Dias EJC; Filho JNC; Bastos REA; Godoy ALPC; Azeredo FJ; Pedreira JNR; Couto RD
    Curr Pharm Biotechnol; 2019; 20(4):346-351. PubMed ID: 30892160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
    Garrett DO; Jochimsen E; Murfitt K; Hill B; McAllister S; Nelson P; Spera RV; Sall RK; Tenover FC; Johnston J; Zimmer B; Jarvis WR
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):167-70. PubMed ID: 10100541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
    Pai MP; Neely M; Rodvold KA; Lodise TP
    Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic monitoring of vancomycin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2014 Oct; 60(10):846-51. PubMed ID: 25382007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of hemodialysis clearance parameter for vancomycin therapeutic drug monitoring during continuous hemodiafiltration in an infant.
    Shiohira H; Isagawa S; Yamada S; Sunagawa S; Nakamatsu M; Yonaha F; Hokama N; Fujita J; Nakamura K
    Pharmazie; 2018 Dec; 73(12):737-739. PubMed ID: 30522560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.
    Sicard M; Launay E; Caillon J; Jacqueline C; Legrand A; Deslandes G; Navas D; Rozé JC; Guen CG
    Eur J Clin Pharmacol; 2015 May; 71(5):611-5. PubMed ID: 25740677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.
    Chong J; Quach C; Blanchard AC; Poliquin PG; Golding GR; Laferrière C; Lévesque S
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5673-81. PubMed ID: 27401579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the treatment of sepsis with vancomycin in term newborn infants.
    Machado JK; Feferbaum R; Diniz EM; Okay TS; Ceccon ME; Costa Vaz FA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):17-24. PubMed ID: 11378679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
    Pharmacotherapy; 2009 Nov; 29(11):1275-9. PubMed ID: 19873687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
    Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
    J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative mediastinitis due to methicillin resistant Staphylococcus epidermidis with low sensitivity to vancomycin].
    Hulin S; Durandy Y
    Arch Pediatr; 1997 Dec; 4(12):1204-6. PubMed ID: 9538424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.